Important Regulatory Update for Biocidal Active Substances

The update extends the review program for all existing biocidal active substances until December 31, 2030.

Why is this important?

The European Commission has issued Delegated Regulation (EU) 2024/1398, amending Regulation (EU) No 528/2012. This update extends the review program for all existing biocidal active substances until December 31, 2030.

Key Points:

• Extended Deadline: The systematic examination of active substances contained in biocidal products will now run until the end of 2030 instead of the end of 2024.
• Why the delay? Challenges include limited resources, complex technical issues, and new scientific criteria for endocrine disruptors.
• Compliance: Ensure your compliance processes are updated to align with these changes.

🔍 Impact: This extension aims to ensure thorough evaluation, improving safety and environmental protection standards.

More Important Deadlines:

• Member states must request missing data on endocrine effects by June 30, 2024.
• Applicants have until December 31, 2026, to submit this data.
• Post-2026, evaluations will proceed based on submitted data or face rejection.

📅 Effective Date: June 11, 2024

If you need assistance with your regulatory challenges, please contact our experienced team!